Acuitas Therapeutics

Acuitas Therapeutics on fru.dev

Acuitas Therapeutics across fru.dev: timeline

  1. Acuitas takes a majority stake in RNA Technologies & Therapeutics (Emerging)
  2. First patient treated with a personalized base editor delivered by lipid nanoparticles (Emerging)

Sources